|
More
Oncology
Research Library
|
|
SK&A, A Cegedim Company
|
Pharma promotion spend dropped by 10 percent compared to summer 2010, despite new product introductions, according to this report from Cegedim Strategic Data. This report reveals the top five cancer categories and pharma manufacturers ranked by promotional spending. Use this report to understand and compare the marketing channels that pharma companies are utilizing for oncology products.
All ...
|
|
|
BioClinica
|
Functional challenges aside, electronic data capture can improve cancer clinical trials.
Oncology compounds comprise about one third of the development projects in the pharmaceutical and biotech industry (see Figure 1). The features of oncology projects, while not unique to this therapeutic area, do create unique challenges and opportunities in clinical study management. These clinical programs ...
|
|
|
Quanticate Limited.
|
|
|
|
Varian Medical Systems, Inc.
|
VARIAN MEDICAL SYSTEMS | CLINICAL PERSPECTIVES | IMRT
A Review of Intensity Modulated Radiation Therapy (IMRT): A Cost Effective, Personalized Form of Radiation Therapy
Radiation therapy (RT) is used to treat approximately 67% of cancer patients in the US, one or more times during the course of their treatment, or about 1 million patients per year (ASTRO fact sheet, 2009).
In the early 1990s, ...
|
|
|
CoreLab Partners, Inc.
|
The Food & Drug Administration (FDA) advocates blinded independent central review (BICR) of radiographic exams for registrational oncology studies when the primary endpoint is based on tumor measurements such as progression-free survival, time to progression or objective response rate. Current FDA guidance recommends multiple independent readers evaluate each subject during BICR. One consequence ...
|
|
|
|
